[1]
, P.S., Ajay Kumar, Jyotiprakash Bhanja, Rahaman Shaik, Akash Limba Kawale and Roshan Kumar 2022. A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology. 9, 3 (Jun. 2022), 201–209.